Money and Me: 3 Singapore REITs at a Turning Point

Market View: Earnings Season Begins - Will JPMorgan, Netflix and AI Giants Set the Market's Next Big Move?

Hosted by Michelle Martin, this episode previews a pivotal week for investors as earnings season kicks off with JPMorgan Chase and Netflix, while fresh inflation data and renewed U.S.-Iran tensions add another layer of uncertainty. We unpack Bank of America's top earnings picks, ask whether AI momentum can continue after standout performances from SK Hynix and Meta. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Money and Me: 3 Singapore REITs at a Turning Point

Should you buy a REIT before it recovers? How can you tell if a REIT is on the path of recovery? Michelle finds out in this discussion as more investors ask if Singapore's beaten-down property trusts are finally turning the corner, or if the rebound is only temporary. After years of higher interest rates and weaker distributions, investors are looking for signs of a sustained recovery. Hosted by Michelle Martin, this episode examines three REITs to watch: Mapletree Logistics Trust, Mapletree Pan Asia Commercial Trust and Frasers Centrepoint Trust. We explore what their upcoming results could reveal about logistics demand, retail resilience, asset recycling, financing costs and the transformative potential of the Johor Bahru–Singapore RTS Link. If you're hunting for income, this conversation highlights the metrics that matter most before making your next investment decision. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Market View: AI's New Battleground, SK Hynix's Record Debut & Winners and Losers

In this episode, hosted by Michelle Martin, we unpack SK Hynix's record-breaking US$26.5 billion U.S. listing and why investors are pouring money into the critical infrastructure powering artificial intelligence. We explore Meta's move into AI coding, OpenAI's launch of its long-awaited AI "super app," and the growing legal battle over whether AI companies should compensate news publishers for the content that trains their models. We also check in on a steadier Wall Street as geopolitical tensions ease and examine what calmer markets mean for investors. Finally, we look at why the next stage of the AI revolution may be won not just by software developers- but by the companies building the chips, memory and infrastructure behind it. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Live Well with Michelle: The next era of intelligence - building living computers

Artificial intelligence has transformed the way we work, but could the next computing revolution come from biology instead? Hosted by Michelle Martin, this episode explores the groundbreaking field of biological computing with Dr Chong Hon Weng, Founder and CEO of Cortical Labs. Discover how lab-grown human neurons are being fused with silicon chips to create computers that learn in fundamentally different ways from today's AI. We explore why Singapore is home to the country's first Biological Data Centre, how this technology could accelerate drug discovery for neurological diseases, dramatically reduce AI's energy consumption, and reshape robotics, cybersecurity and healthcare. Finally, Dr Chong tackles the ethical questions surrounding the use of living human brain cells and shares his vision for the future of intelligence itself. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.